Tsingke Biotechnology

Provider of synthetic biology products and services

placeBeijing, Beijing, China calendar_todayFounded 2012 language tsingke.com.cn

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
China95.4%
United States3%
Hong Kong0.8%
Japan0.5%
Thailand0.2%

Investor mix

8 investors on record; lead investors include Henan Investment Group Huirong Fund, Fortune Capital.

Investor typeCountShare
Venture capital450%
Private equity113%
Other / undisclosed338%

Share of voice

Share of voice in China: 100% of web traffic across its competitive set; worldwide: 1.8%.

Coming soon